Shawn Marshall Rose
Chief Medical Officer, Head of Research & Development · Nkarta, Inc.
Individual
- 2026
- Jan 8, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Shawn Marshall Rose files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Paul J. Hastings - $59K in NKTX purchases and sales in the last 12 months
- Nadir Mahmood - $12K in NKTX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Shawn Marshall Rose?
Shawn Marshall Rose is a corporate insider, tracked as Chief Medical Officer, Head of Research & Development of Nkarta, Inc. (NKTX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Shawn Marshall Rose last file a Form 4?
The only primary Form 4 on record is dated 8 January 2026.
